Lucid Diagnostics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lucid Diagnostics generated cash of -$32,817,000, which is less than the previous year. Cash used in financing activities reached the amount of $29,460,000 last year. Net change in cash is therefore -$3,578,000.

Cash Flow

Lucid Diagnostics Inc. (NASDAQ:LUCD): Cash Flow
2019 -2.36M 0 2.5M
2020 -5.62M 0 5.58M
2021 -17.66M -862K 72.07M
2022 -29.68M -4.10M 2.61M
2023 -32.81M -221K 29.46M

LUCD Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
22.47M53.65M111K156.40K17.8K
Operating activities
Net income
-52.66M-56.17M-28.07M-8.27M-4.42M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
2.49M1.93M4K00
Stock-based compensation expense
6.82M14.99M9.59M65K173.94K
Deferred income tax benefit 6.82M14.99M9.59M65K173.94K
Changes in operating assets and liabilities:
Accounts receivable, net
-28K183K-200K00
Inventories
00000
Accounts payable
89K-445K-665K1.14M301.85K
Cash generated by operating activities
-32.81M-29.68M-17.66M-5.62M-2.36M
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-221K-908K-862K00
Acquisitions Net
0-3.2M000
Cash generated by investing activities
-221K-4.10M-862K00
Financing activities
Common Stock Issued
284K1.80M70M5.58M2.5M
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
10M0000
Cash used in financing activities
29.46M2.61M72.07M5.58M2.5M
Net Change In Cash
-3.57M-31.18M53.54M-45.14K138.60K
Cash at end of period
18.89M22.47M53.65M111.25K156.40K
Data sourceData sourceData source